Thromb Haemost 2020; 120(08): 1208-1216
DOI: 10.1055/s-0040-1713095
Stroke, Systemic or Venous Thromboembolism

Comparison of Effectiveness between Anticoagulation and Thrombolysis Therapy for Pulmonary Embolism in Patients Complicated with Shock: A Nationwide Population-Based Study

Jen-Kuang Lee*
1  Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan
2  Department of Laboratory Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan
3  Cardiovascular Center, National Taiwan University Hospital, Taipei, Taiwan
4  Telehealth Center, National Taiwan University Hospital, Taipei, Taiwan
,
Wen-Hsin Chen*
5  Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Keelung, Taiwan
,
Yu-Sheng Lin
6  Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Chaiyi, Taiwan
,
Chih-Hsiang Chang
7  Graduate Institute of Clinical Medical Science, College of Medicine, Chang Gung University, Taoyuan, Taiwan
8  Department of Nephrology, Kidney Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan
,
Tien-Hsing Chen
5  Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Keelung, Taiwan
6  Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Chaiyi, Taiwan
9  Department of Medicine, Chang Gung University, Taoyuan, Taiwan
10  Biostatistical Consultation Center of Chang Gung Memorial Hospital, Keelung, Taiwan
› Institutsangaben
Funding This work was supported by grants from the Chang Gung Memorial Hospital, Taiwan (CGRPG2F0011, CLRPG2C0021, CLRPG2C0022, CLRPG2C0023, CLRPG2C0024, CLRPG2G0081, and CLRPG2G0082), the Ministry of Science and Technology of Taiwan (MOST 108–2221-E-002–163-), and National Taiwan University Hospital (107-EDN11, 108-N4406, 108EDN02, 109-O20, 109-S4579).

Abstract

Objective This study aimed to compare the efficacy of anticoagulation therapy and thrombolytic therapy for pulmonary embolism (PE) in patients complicated with shock.

Methods This retrospective cohort study used administrative data from Taiwan's National Health Insurance Research Database. Patients admitted due to PE who received inotropic support between January 1, 1997, and December 31, 2011, were included. To closely mimic a randomized experiment, anticoagulation and thrombolysis plus anticoagulation groups were subjected to propensity score matching (PSM) according to demographic characteristics, comorbidities, and inotropic agent dosage. The primary outcome was in-hospital mortality. The secondary outcome was 3-month mortality after discharge.

Results After PSM, a total of 820 patients, including 164 thrombolysis and 656 anticoagulation patients, were enrolled. The in-hospital mortality was 48.2% in the thrombolysis group and 52.4% in the anticoagulation group (odds ratio [OR] 0.84, 95% confidence interval [CI] 0.59–1.18). Major bleeding occurred in 19 (11.6%) of the thrombolysis patients and 57 (8.7%) of the anticoagulation patients (OR 1.37, 95% CI, 0.79–2.38). The 90-day mortality rates in the thrombolysis and anticoagulation groups were 15.3% (13 patients) and 17.6% (55 patients), respectively; this difference was not significant (hazard ratio 0.88, 95% CI 0.48–1.61).

Conclusion In PE patients complicated with shock, anticoagulation therapy provides similar treatment efficacy to thrombolytic therapy in terms of in-hospital and 90-day mortality. The bleeding risk was also similar in the two treatment groups.

* Jen-Kuang Lee and Wen-Hsin Chen contributed equally to this study.


Supplementary Material



Publikationsverlauf

Eingereicht: 23. März 2020

Angenommen: 01. Mai 2020

Publikationsdatum:
17. Juli 2020 (online)

Georg Thieme Verlag KG
Stuttgart · New York